Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amnio-Maxx
- Development stage
- Phase 4
- Lead developer
- Royal Biologics
- Administration
- Topical
01
Overview
Amnio-Maxx is a human placental-derived tissue product, specifically a dual-layer amnion patch, developed by Royal Biologics. Categorized as a cellular, acellular, matrix-like product (CAMP), it is designed to facilitate wound healing in chronic and complex conditions, most notably non-healing diabetic foot ulcers (DFUs). The product utilizes the natural properties of the amniotic membrane, which is rich in regenerative growth factors, cytokines, and extracellular matrix (ECM) proteins such as collagen, fibronectin, and laminin. These components provide a biological scaffold that promotes cell migration, proliferation, and epithelialization while modulating inflammation and reducing scarring. Amnio-Maxx is typically applied topically to the wound bed following standard debridement as part of a comprehensive wound care regimen.
- Brand names
- Amnio-Maxx
- Other names
- Amnio-Maxx Dual Layer Amnion Patch
Beyond the preview
Go deeper on Amnio-Maxx.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amnio-Maxx.